Back to Atlas
BSemi-durableStandard research/education caution
CMP-0802
Research chemical/reference listing
NIM811
Longevity / senescence / mitochondrial
Aging biology, resilience, and durable cellular-function support
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Longevity / geroprotector compound
- Primary mechanism
- Senescence, telomere, mitochondrial, or cellular stress pathway modulation
- Primary market use
- Longevity / senescence / mitochondrial
Pharmacology
- Molecular weight (Da)
- 1202.61
- Oral bioavailability
- Route-dependent / verify
- Half-life
- ~1–12 h provisional PK estimate
- Route tags
- Oral
- Evidence level
- MCE product listing / research chemical signal
- Clinical status
- Research chemical/reference listing
- Value-for-money score
- 7 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
NIM811 ((Melle-4)cyclosporin; SDZ NIM811) is an orally bioavailable mitochondrial permeability transition and cyclophilin dual inhibitor, which exhibits potent in vitro activity against hepatitis C virus ( HCV ) .